Atlas Genetics Ltd. has appointed Marc Jones chief operating officer and chief financial officer. Jones will be reunited with former colleague, Jeffrey Luber, Atlas' recently appointed CEO. Both Lub
Device Transactions Financing by device companies in the third quarter of 2017 totaled $2.38 billion, double Q2's $1.2 billion. ( See Exhibit 1. ) Debt again this quarter made up most of the aggregate
Invitae Corp. is scooping-up two acquisitions to further expand its genetic test offerings, currently focused on inherited adult and pediatric conditions, into the reproductive health arena. The San
Company Changes ALEXANDER , Dana M. To: Anika Therapeutics Inc. , COO (April) From: Genzyme Corp., Senior Dir., Biologics Mfg. Ops. Phone: 781-457-9000 BERK , Gregory I., MD To: Verastem In